Summary

Splits the National Institute of Allergy and Infectious Diseases (NIAID) into three separate institutes focused on allergic diseases, infectious diseases, and immunologic diseases. It reorganizes statutory authority and references, terminates the existing NIAID Director position at enactment, and sets new presidential appointment rules and fixed terms for the three new institute directors. Makes conforming changes across multiple federal statutes so existing references to NIAID point to the appropriate new institute, transfers certain statutory provisions into newly created institute sections, and places the NIH Director in temporary oversight until presidential appointees take office.

• Splits the single institute for allergy and infectious disease into three distinct institutes for allergy, infectious disease, and immunologic disease.
• Creates new statutory sections and reorganizes existing statutory provisions to reflect the three-institute structure.
• Terminates the existing institute director position at enactment and places NIH Director in temporary oversight until new directors are appointed.
• Requires presidential appointment for each new institute director with 5-year terms and a one-time reappointment limit.
• Directs that existing statutory references to the old institute will be treated as references to the appropriate new institute(s).
• Imposes administrative changes across NIH grant, contracting, and organizational references but does not specify new appropriations.
• Transfers and redesignates several existing statutory provisions into newly numbered sections for the new institutes.
• Likely triggers operational work to update regulations, grant documentation, staffing assignments, and interagency agreements.
• Focuses on institutional structure and governance rather than on new program content or funding levels.